| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 11 |
| 1 | IPILIMUMAB | 9 |
| 2 | LATANOPROST | 6 |
| 3 | PEMBROLIZUMAB | 6 |
| 4 | TIMOLOL | 4 |
| 5 | ADALIMUMAB | 3 |
| 6 | ANTI ITCH | 3 |
| 7 | ANTI-ITCH | 3 |
| 8 | ANTI-ITCH CREAM | 3 |
| 9 | ANTI-PRURITIC | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BROMPHENIRAMINE MALEATE | 2 | 0.0056 |
| 1 | TEBENTAFUSP | 1 | 0.0017 |
| 2 | TALIMOGENE LAHERPAREPVEC | 2 | 0.0013 |
| 3 | IMIQUIMOD | 2 | 0.0009 |
| 4 | ALDESLEUKIN | 1 | 0.0008 |
| 5 | SALICYLIC ACID 12% | 1 | 0.0005 |
| 6 | ASTRINGENT | 1 | 0.0005 |
| 7 | LIQUID CORN AND CALLUS REMOVER | 1 | 0.0005 |
| 8 | BENZOYL PEROXIDE | 3 | 0.0004 |
| 9 | TIMOLOL | 4 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 9 | 0.0002 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 15 | 0.0002 |
| 4 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 5 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 6 | Prostaglandin Analog [EPC] | 6 | 0.0001 |
| 7 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 8 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |
| 9 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |